Medication error when switching from warfarin to rivaroxaban leading to spontaneous large ecchymosis of the abdominal and chest wall

Medication error when switching from warfarin to rivaroxaban leading to spontaneous large ecchymosis of the abdominal and chest wall

Non-vitamin K oral anticoagulant (NOAC) therapy may be inappropriate if prescription was incorrect, the patient’s physiological parameters change, or interacting concomitant medications are erroneously added. The aim of this report was to illustrate inappropriate NOAC prescription in a 78-year-old w...

Descripció completa

Dades bibliogràfiques
Autors principals:	Flavio Egger, Federica Targa, Ivan Unterholzner, Russell P. Grant, Markus Herrmann, Christian J. Wiedermann
Format:	Article
Idioma:	English
Publicat:	MDPI AG 2016-08-01
Col·lecció:	Clinics and Practice
Matèries:	Direct oral anticoagulants therapeutic drug monitoring drug safety drug-drug interaction pharmacovigilance anticoagulant reversal
Accés en línia:	https://www.clinicsandpractice.org/index.php/cp/article/view/873

Ítems similars

Warfarin interactions: a letter to editor
per: Sayyed Majid Sadrzadeh, et al.
Publicat: (2019-10-01)

Case report: Medical cannabis—warfarin drug-drug interaction
per: Tyan F. Thomas, et al.
Publicat: (2022-01-01)

A rare case of Diffuse Alveolar Hemorrhage (DAH) due to warfarin toxicity
per: Borjian Solmaz, et al.
Publicat: (2020-03-01)

Advances in Monitoring and Reversal Strategies for the Novel Anticoagulants Factor Ⅺ Inhibitors
per: CHEN Yuexiu, YAO Yuanyuan, SUN Dawei, WANG Ying, WU Chaomin, ZHAO Linqian, TANG Zhifeng, ZHANG Fengjiang
Publicat: (2025-01-01)

Warfarin-Induced Limb Contusion and Haematoma
per: Soumya, et al.
Publicat: (2023-04-01)

Warfarin: pharmacological profile and drug interactions with antidepressants
per: Juliana Souto Teles, et al.
Publicat: (2012-03-01)

Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report)
per: N. T. Vatutin, et al.
Publicat: (2020-03-01)

Suspected Rivaroxaban-Induced Anaphylaxis Secondary to Ingestion of Rivaroxaban and Nimesulide Without Cross-Reactivity to Dabigatran – A Case Report
per: Gumbis G, et al.
Publicat: (2023-10-01)

Applied Nanotechnologies in Anticoagulant Therapy: From Anticoagulants to Coagulation Test Performance of Drug Delivery Systems
per: Yuri B. G. Patriota, et al.
Publicat: (2021-05-01)

Possible interaction of warfarin with peppermint herbal tea: a case report
per: Aliasghar Moeinipour, et al.
Publicat: (2017-05-01)

The Prevalence and Risks of Inappropriate Combination of Aspirin and Warfarin in Clinical Practice: Results From WARFARIN-TR Study
per: Salih Kılıç, et al.
Publicat: (2019-01-01)

Anticoagulation Drug Therapy: A Review
per: Harter, Katherine, et al.
Publicat: (2015-01-01)

Warfarin: pharmacological profile and drug interactions with antidepressants
per: Juliana Souto Teles, et al.
Publicat: (2012-03-01)

Effects of sodium ferulate for injection on anticoagulation of warfarin in rats in vivo
per: Yue Zhao, et al.
Publicat: (2024-02-01)

Atrial Fibrillation Patients Treated With Long‐Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long‐Term Warfarin for Other Indications
per: T. Jared Bunch, et al.
Publicat: (2016-07-01)

Research progress of antithrombotic drugs
per: ZHANG Jie, MA Xuzhou, LI Huihui, WANG Miao
Publicat: (2023-01-01)

Assessing the link between rivaroxaban concentration and the onset of renal impairment in elderly patients: A retrospective observational study
per: Motakatla Usha Rani, et al.
Publicat: (2024-06-01)

An Assessment of Osteoporotic Conditions among Users and Non-Users of Warfarin: A Case-Control Study
per: Aseel Hadi Abdulameer, et al.
Publicat: (2017-03-01)

ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS
per: O. V. Shatalova, et al.
Publicat: (2015-09-01)

ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS
per: O. V. Shatalova, et al.
Publicat: (2015-09-01)

Idiosyncratic Liver Injury due to Rivaroxaban
per: Aneesh Cherakulam Ratheendran, et al.
Publicat: (2017-12-01)

Risks of oral anticoagulants: Analysis of adverse drug reactions reported to the Portuguese National Pharmacovigilance System
per: Ana Sofia Martins, et al.
Publicat: (2024-10-01)

Profile and outcome of patients with Warfarin Toxicity admitted in a tertiary care hospital in Bhutan: a cross-sectional study investigators and institutions
per: Yeshey Penjore, et al.
Publicat: (2023-05-01)

Bleeding complications following intramuscular injections among hospitalized anticoagulated patients: a retrospective observational comparative study
per: Marina Davidov, et al.
Publicat: (2024-10-01)

Apixaban dosing in hemodialysis - can drug level monitoring mitigate controversies?
per: Simeon Schietzel, et al.
Publicat: (2024-10-01)

Assessment of prescribing pattern and adverse drug reaction in patients receiving anticoagulant therapy: A prospective observational study
per: Thangavel Mahalingam Vijayakumar, et al.
Publicat: (2023-08-01)

Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
per: Ki Won Hwang, et al.
Publicat: (2023-04-01)

Bleeding Risk Related to Upper Gastrointestinal Endoscopic Biopsy in Patients Receiving Antithrombotic Therapy: A Multicenter Prospective Observational Study
per: Takafumi Yuki, MD, PhD, et al.
Publicat: (2017-01-01)

Interaction between Levothyroxine and Phenprocoumon: a case report
per: Gaeti Walderez, et al.
Publicat: (2014-04-01)

Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
per: Brandon K. Martinez, et al.
Publicat: (2018-04-01)

Levofloxacin: Analysis of Information on Adverse Reactions from Russian Spontaneous Report Database
per: S. K. Zyryanov, et al.
Publicat: (2020-05-01)

Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study
per: Anne-Laure Sennesael, et al.
Publicat: (2018-11-01)

Advancing anticoagulation stewardship: A call to action for stewardship from the US-based anticoagulation forum
per: Allison Burnett, et al.
Publicat: (2022-12-01)

Potential drug-drug interactions among patients with spontaneous intracerebral hemorrhage treated at the Neurological Intensive Care Unit: a single-center experience
per: Dejan Z. Aleksić, et al.
Publicat: (2022-11-01)

Analysis of spontaneous reporting of suspected adverse drug reactions for non-analgesic over-the-counter drugs from 2008 to 2017
per: Josipa Bukic, et al.
Publicat: (2019-10-01)

Investigation of possible prophylactic, renoprotective, and cardioprotective effects of thromboprophylactic drugs against ischemia–reperfusion injury
per: Sinan Demirtas, et al.
Publicat: (2015-03-01)

Assessing the Comparative Efficacy and Safety of Warfarin and Rivaroxaban for Cancer Associated Thrombosis: Experience From a Resource Limited Setting
per: Abel Tenaw Tasamma, et al.
Publicat: (2025-01-01)

Anticoagulants - The Past, The Present, The Future - A Systematic Review
per: Klaudia Warzycka, et al.
Publicat: (2024-05-01)

Pharmacological analysis and remote monitoring of a patient with skin ulcers caused by anticoagulation
per: Wu Ling, et al.
Publicat: (2023-12-01)

Association between direct oral anticoagulant concentrations and clinical outcomes: A systematic review and meta-analysis
per: Brandon Stretton, et al.
Publicat: (2023-12-01)